SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Flannery O'Connor

PatientFlannery O'Connor
Date of birth2001-03-25
IdentifiersMRN HR-ML046-SYN; SSN (made up) 000-46-1853
Document date2026-04-22
AuthorAugusta Pemberton-Diallo, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Results of the lupus tests; rheumatology consultation today. [S]

History of Present Illness

Ms. O'Connor returns nine days after presenting with three months of painful, swollen hands, wrists, and knees, evening fevers, fatigue, a facial rash after sun, and protein and blood in her urine. She saw Dr. Okonjo-Strand this morning, and the tests drawn there returned this afternoon: ANA positive at 1:640 in a homogeneous pattern, anti-dsDNA 186 IU/mL, anti-Sm 42 U/mL, and low complements (C3 62, C4 8 mg/dL). Anticardiolipin and anti-beta-2 glycoprotein I antibodies are negative and the lupus anticoagulant test is negative. The urine protein-to-creatinine ratio is 1.8 g/g, with 22 red cells per high-power field, many of them misshapen, and a red cell cast; creatinine is 0.8. Hepatitis B surface antigen is negative with a positive surface antibody, and hepatitis C and HIV tests are negative; a pregnancy test is negative. Before the results were given she was asked how she wanted to hear them and said she wanted all of it, at once. She was told directly that she has systemic lupus erythematosus, that the urine findings mean the kidneys are probably involved, and that a kidney biopsy is needed to choose treatment; she knows that her father had lupus, and was told plainly that treatment and outlook today are very different. She repeated it back accurately. She asked that her diagnosis not be shared with anyone she has not named. [S]

ElementDetail
SerologyANA 1:640 homogeneous; anti-dsDNA 186; anti-Sm 42; C3 62, C4 8; antiphospholipid antibodies and lupus anticoagulant negative
KidneyProtein-to-creatinine ratio 1.8 g/g; active sediment with a red cell cast; creatinine 0.8
Infection screeningHepatitis B immune by vaccination; hepatitis C and HIV negative
DisclosureTold the diagnosis directly; teach-back correct; privacy request recorded
CoordinationRheumatology seen this morning; kidney biopsy in two days

Review of Systems

SystemResultFinding
ConstitutionalPositiveEvening fevers to 37.8 °C and fatigue
MusculoskeletalPositivePainful, swollen hand joints and knees; an hour of morning stiffness
IntegumentaryPositiveFacial rash after sun; some hair shedding
Ears, nose, mouth, and throatPositiveA painless sore on the roof of the mouth
RespiratoryNegativeNo pleuritic chest pain or breathlessness
GenitourinaryNegativeNo foamy urine noticed; no swelling of the legs
PsychiatricPositiveWorried but composed; no thoughts of self-harm

7 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth up to three times a day as needed for joint pain, no more than 3000 mg a dayTwo tablets up to every 8 hours as neededOral route2026-04-13activeS
Hydroxychloroquine sulfate 300 mg oral tablet, one tablet by mouth once daily (5 mg/kg of actual body weight), long termOne tablet once dailyOral route2026-04-22activeS
Losartan potassium 25 mg oral tablet, one tablet by mouth once daily, for proteinuria and blood pressureOne tablet once dailyOral route2026-04-22activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-04-22Body height168cmS
2026-04-22Body weight59.6kgS
2026-04-22Body mass index (BMI) [Ratio]21.1kg/m2S
2026-04-22Systolic blood pressure136mm[Hg]S
2026-04-22Diastolic blood pressure84mm[Hg]S
2026-04-22Heart rate92/minS
2026-04-22Respiratory rate16/minS
2026-04-22Body temperature37.6CelS
2026-04-22Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-04-22Nuclear Ab [Titer] in Serum by Immunofluorescence640{titer}Negative at 1:40 or less; the EULAR/ACR entry criterion is 1:80 or higherHighS
2026-04-22DNA double strand Ab [Units/volume] in Serum186[IU]/mL<=29 [IU]/mLHighS
2026-04-22Smith extractable nuclear Ab [Units/volume] in Serum42U/mL<=19 U/mLHighS
2026-04-22Complement C3 [Mass/volume] in Serum or Plasma62mg/dL90-180 mg/dLLowS
2026-04-22Complement C4 [Mass/volume] in Serum or Plasma8mg/dL10-40 mg/dLLowS
2026-04-22Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay6U/mL<=20 U/mLNormalS
2026-04-22Cardiolipin IgM Ab [Units/volume] in Serum by Immunoassay4U/mL<=20 U/mLNormalS
2026-04-22Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum3U/mL<=20 U/mLNormalS
2026-04-22Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum2U/mL<=20 U/mLNormalS
2026-04-22dRVVT/dRVVT W excess phospholipid (screen to confirm ratio)1.04{ratio}<=1.2NormalS
2026-04-22Protein/Creatinine [Mass Ratio] in Urine1.8g/g<=0.2 g/gHighS
2026-04-22Erythrocytes [#/area] in Urine sediment by Microscopy high power field22/[HPF]<=2 /[HPF]HighS
2026-04-22Creatinine [Mass/volume] in Serum or Plasma0.8mg/dL0.5-1.1 mg/dLNormalS
2026-04-22Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M101mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS

Physical Exam

Vital signs recorded on 2026-04-22; see the Vital Signs section. [S]

SystemFinding
GeneralTired but engaged; temperature 37.6 °C
SkinRed, slightly raised rash over both cheeks and the bridge of the nose, sparing the nasolabial folds; diffuse thinning of the scalp hair
MouthPainless 4 mm ulcer on the hard palate
MusculoskeletalSynovitis of the second and third knuckles and middle finger joints of both hands and both wrists; small knee effusions
CardiovascularNo rub; no edema
RespiratoryClear; no rub

Problems

ProblemClinical statusVerificationCodeProvenance
Pain and swelling of the small joints of both hands, the wrists, and the knees for three months, with an hour of morning stiffness, evening fevers to 38 °C, fatigue, and a red rash over the cheeks and nose after sun; told elsewhere it might be rheumatoid arthritis; cause to be establishedresolvedconfirmed M25.50S — Synthetic presenting concern at the index visit, superseded by the diagnosis of systemic lupus erythematosus at the second visit; joint pain in 1950 with suspected rheumatoid arthritis is documented (D).
Protein and blood in the urine: protein-to-creatinine ratio 1.6 g/g and 18 red cells per high-power field, with normal creatinine; cause to be establishedactiveconfirmed R80.9S — Synthetic presenting finding at the index visit, superseded by the kidney biopsy diagnosis at the third visit.
Systemic lupus erythematosus, classified by the EULAR/ACR criteria (ANA 1:640 homogeneous; score 32 before the biopsy): inflammatory arthritis, acute cutaneous lupus (malar rash), fever, leukopenia with lymphopenia, mild thrombocytopenia, low C3 and C4, anti-dsDNA and anti-Sm positive; antiphospholipid antibodies and lupus anticoagulant negativeactiveconfirmed M32.19S — Synthetic modern diagnosis and results; her systemic lupus erythematosus, diagnosed in Atlanta in late 1950 or early 1951, is documented (D), but no finding from her lifetime is used.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
LaboratoryClassification: ANA and the EULAR/ACR criteriaAt diagnosisCompleted todayANA 1:640; criteria score 32
LaboratoryAnti-dsDNA, anti-Sm, C3, and C4At diagnosis, then every 3 months while activeCompleted todayAnti-dsDNA 186, anti-Sm 42, C3 62, C4 8
LaboratoryAntiphospholipid antibodies and lupus anticoagulantAt diagnosisCompleted todayAnticardiolipin IgG 6 and IgM 4, anti-beta-2 glycoprotein I IgG 3 and IgM 2, dRVVT ratio 1.04: all negative
LaboratoryUrine protein-to-creatinine ratio and urine sedimentAt diagnosis, then every 3 monthsCompleted today1.8 g/g; 22 red cells per high-power field with dysmorphic cells and a red cell cast
LaboratoryCreatinine and eGFRAt diagnosis, then every 3 monthsCompleted todayCreatinine 0.8, eGFR 101
LaboratoryBlood countAt diagnosisUp to dateNine days ago: white cells 3.3, lymphocytes 0.8, hemoglobin 11.0, platelets 138
ImagingKidney biopsyWhen proteinuria is 0.5 g/g or more, or with an active sedimentOrderedBooked in two days
LaboratoryHepatitis B, hepatitis C, and HIV screening before immunosuppressionBefore immunosuppressionCompleted todayHepatitis B surface antigen negative, surface antibody positive; hepatitis C and HIV negative
Medication safetyVaccinations before immunosuppressionBefore immunosuppression when possibleCompleted todayPCV20 and recombinant zoster dose 1 today; influenza given in October; COVID-19 due
Medication safetyHydroxychloroquine dose and baseline eye examinationDose at start; eye examination within the first yearDue300 mg daily, 5 mg/kg; ophthalmology booked
ExaminationBlood pressureEvery visitCompleted today136/84 mmHg, above target; losartan started
Medication safetyPregnancy test and contraception before mycophenolateBefore the first doseOrderedPregnancy test negative today; intrauterine system booked
Self-managementDisclosure and shared decisionsAt diagnosis and with every resultCompleted todayTold directly; teach-back correct; written summary given
Self-managementSun protectionEvery visitCompleted todaySunscreen SPF 50, a hat, and midday shade
SurveyDepression screen (PHQ-9)At diagnosis, then periodicallyUp to datePHQ-9 7 nine days ago; supportive care

Goal progress:

Immunizations given today: Pneumococcal conjugate vaccine PCV20; Recombinant zoster vaccine, dose 1 of 2 [S]

Guideline basis: 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol 2019;71(9):1400-1412 (2019); EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis 2024;83(1):15-29 (2023); 2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis. Arthritis Rheumatol 2025;77(9):1115-1135 (2024); 2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases. Arthritis Rheumatol 2023;75(3):333-348 (2022); 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. Arthritis Care Res 2020;72(4):461-488 (2020)

Follow-up: Kidney biopsy in two days; intrauterine system next week; primary care review with the biopsy result in one week. Next scheduled visit 2026-04-29: kidney biopsy result: class III lupus nephritis; start of pulse methylprednisolone, prednisone, mycophenolate, and belimumab. [S]